Cultureplaces

BY CALIFORNIA INSTITUTE OF TECHNOLOGY ON APRIL 14, 2016  COGNITION Why do we sometimes decide to take risks and other times choose to play it safe? In a new study, Caltech researchers explored the neural mechanisms of one possible explanation: a contagion effect. The work is described in the March 21 online early edition of the Proceedings of the National Academy of Sciences . In the study led by John O’Doherty, professor of psychology and director of the Caltech Brain Imaging Center, 24 volunteers repeatedly participated in three types of trials: a “Self” trial, in which the participants were asked to choose between taking a guaranteed $10 or making a risky gamble with a potentially higher payoff; an “Observe” trial, in which the participants observed the risk-taking behavior of a peer (in the trial, this meant a computer algorithm trained to behave like a peer), allowing the participants to learn how often the peer takes a risk; and a “Predict” trial, in which the part

Jamie M. Gajos 1,* ,  Abigail A. Fagan 2 and Kevin M. Beaver 3 Article first published online: 15 APR 2016 Criminology and Public Policy DOI: 10.1111/1745-9133.12214 Research Summary In this article, we outline the potential ways that genetic research can be used to inform the development, testing, and dissemination of preventative interventions. We conclude by drawing attention to how the incorporation of genetic variables into prevention designs could help identify individual variability in program effectiveness and thereby increase program success rates. Policy Implications Evidence-based prevention science seeking to reduce crime and other related behavioral disorders has made significant progress in the identification of risk factors involved in the development of antisocial behavior, as well as in the creation and testing of such programs intended to target these risk factors. Nonetheless, issues of program effectiveness remain as individual responsivity to p

March 6, 2015 Men with borderline testosterone levels have higher rates of depression and depressive symptoms than the general population, new research finds. The results will be presented Saturday, March 7, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego. "Over half of men referred for borderline  testosterone levels  have  depression . This study found that men seeking management for borderline testosterone have a very high rate of depression, depressive symptoms , obesity and physical inactivity," said principal study author Michael S. Irwig, MD, FACE, associate professor of medicine and director of the Center for Andrology in the Division of Endocrinology at George Washington University in Washington, DC. "Clinicians need to be aware of the clinical characteristics of this sample population and manage their comorbidities such as depression and obesity."